Through some markets are relatively free of profit-blocking restrictions, most markets impose strong barriers to the introduction of genetically genetically engineered crops and foodstuffs. Agrochemical firms that have invested significant resources in biotechnology applications encounter varying degrees of market access and acceptance. Some external stakeholders remain skeptical of the technology, with their refusal to accept in hurting innovators' returns on investment. We explore the tension between the social rationality perspective and the scientific rationality perspective on this issue. Critically evaluating the benefits of each perspective to innovation efforts we make several theoretical and practical recommendations.
Department, Program, or Center
International Journal of Business Strategy
RIT – Main Campus